{"id":"W2164256326","doi":"10.1186/s40064-015-1392-x","title":"A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22","year":2015,"lang":"en","type":"article","venue":"SpringerPlus","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Queen's University; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Cancer Society Research Institute; Ontario Institute for Cancer Research","keywords":"Docetaxel; Medicine; Epirubicin; Oncology; Internal medicine; Breast cancer; Clinical trial; Paclitaxel; Phases of clinical research; Taxane; Chemotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001788584,0.0003125957,0.0004504211,0.0001041277,0.00006579815,0.0000123198,0.0001787728,0.000149037,0.00002131225],"category_scores_gemma":[0.0001140837,0.0002584898,0.00007876693,0.0001907696,0.0001721807,0.00001175634,0.0002215505,0.0001299217,0.000005348582],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001287237,"about_ca_system_score_gemma":0.000375919,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004838076,"about_ca_topic_score_gemma":0.0008695913,"domain_scores_codex":[0.9983696,0.00006180938,0.0003739654,0.0005690037,0.0002430755,0.0003825584],"domain_scores_gemma":[0.9990882,0.00002224782,0.0001761968,0.0004075876,0.0001411019,0.0001646341],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5146508,0.01085658,0.01120679,0.0003584304,0.001122615,0.0001636658,0.001469628,0.0008924183,0.1540367,0.0006119261,0.001588306,0.3030421],"study_design_scores_gemma":[0.6921525,0.03252026,0.04095932,0.001335632,0.0004434033,0.000144659,0.002006013,0.0002588719,0.2099868,0.000400179,0.01758957,0.002202804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951547,0.002370592,0.00006678645,0.0008783878,0.0003316977,0.0005297129,0.0001432685,0.00001930404,0.0005055926],"genre_scores_gemma":[0.9976701,0.0005843568,0.0005727006,0.0002019684,0.0002957829,0.0001737868,0.00002047869,0.00003826031,0.0004425867],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3008393,"threshold_uncertainty_score":0.9999867,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02285095882007512,"score_gpt":0.3156169537537927,"score_spread":0.2927659949337176,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}